Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1200 participants
INTERVENTIONAL
2005-08-31
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
placebo resembling misoprostol
placebo
placebo resembling misoprosotl
2
misoprostol
misoprostol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
misoprostol
placebo
placebo resembling misoprosotl
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Vaginal delivery
Exclusion Criteria
* Delivery regarded as abortion according to local gestational age limits
* Inability to take misoprostol sublingually
* Cesarean section
* Assisted vaginal delivery
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Witwatersrand, South Africa
OTHER
Effective Care Research Unit
OTHER
Family Care International
OTHER
Gynuity Health Projects
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Witwatersrand
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lindeka Mangesi
Role: STUDY_DIRECTOR
Effective Care Research Unit, East London Hospital Complex, South Africa
G. J. Hofmeyr, MD
Role: PRINCIPAL_INVESTIGATOR
Effective Care Research Unit, Frere Maternity Hospital, East London Hospital Complex
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University College Hospital
Ibadan, , Nigeria
Tembisa Hospital
Johannesburg, , South Africa
Rob Ferreira Hospital
Mbombela, , South Africa
Dora Nginza Hospital
Port Elizabeth, , South Africa
Mulago Hospital
Kampala, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hofmeyr GJ, Fawole B, Mugerwa K, Godi NP, Blignaut Q, Mangesi L, Singata M, Brady L, Blum J. Administration of 400 mug of misoprostol to augment routine active management of the third stage of labor. Int J Gynaecol Obstet. 2011 Feb;112(2):98-102. doi: 10.1016/j.ijgo.2010.08.019. Epub 2010 Dec 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2.4.5
Identifier Type: -
Identifier Source: org_study_id